Meds Apotek AB (STO:MEDS)
Sweden flag Sweden · Delayed Price · Currency is SEK
24.80
-0.60 (-2.36%)
At close: Jul 23, 2026

Meds Apotek AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
66.6645.1721.1750.5924.7
Cash & Short-Term Investments
66.6645.1721.1750.5924.7
Cash Growth
350.16%113.38%-58.16%104.80%-
Accounts Receivable
24.4825.7624.0114.9514.7
Other Receivables
7.049.134.70.573.3
Total Trade Receivables
31.5234.8928.7215.5218
Inventory
128.84144.17102.2781.7666.6
Other Current Assets
6.715.34.733.531.9
Total Current Assets
233.73229.53156.88151.39111.3
Net Property, Plant & Equipment
17.4417.6536.146.4954.7
Other Intangible Assets
11.9712.2714.5518.0720.1
Long-Term Investments
0.970.790.430.130
Other Long-Term Assets
10.410.460.20.220.2
Total Assets
274.51270.7208.16216.31186.3
Accounts Payable
103.36114.11103.8458.4165.4
Accrued Expenses
25.8317.0918.5216.7414.7
Current Portion of Long-Term Debt
---6.410
Current Portion of Leases
2.387.058.379.767.7
Other Current Liabilities
1.762.411.475.872.6
Total Current Liabilities
133.33140.66132.297.1990.5
Long-Term Debt
---23.330
Long-Term Leases
--15.7225.4131.1
Other Long-Term Liabilities
1.861.651.5722.3
Total Long-Term Liabilities
1.861.6517.2850.7433.4
Total Liabilities
135.2142.31149.48147.93123.9
Common Stock
0.740.740.690.690.6
Additional Paid-in Capital
609.82609.84547.91546.62489.5
Retained Earnings
-471.25-482.19-489.91-478.92-427.8
Shareholders' Equity
139.31128.458.6868.3962.3
Total Liabilities & Equity
274.51270.7208.16216.31186.3
Total Debt
2.387.0524.0864.9138.8
Net Cash (Debt)
64.2838.12-2.92-14.33-14.1
Net Cash Growth
68.62%----
Net Cash Per Share
3.442.14-0.17-0.85-0.92
Book Value
139.31128.458.6868.3962.3
Book Value Per Share
7.457.203.404.084.06
Tangible Book Value
127.34116.1344.1350.3242.2
Tangible Book Value Per Share
6.816.512.563.002.75